IPO Profile: Alder Biopharmaceuticals Inc

Company Details

Location: 11804 N. Creek Parkway South, Bothell, Washington 98011

Phone: (425) 205-2900

Website: www.alderbio.com

Business Description: Alder Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company.

Investment & Return Details

VC backers: Delphi Ventures, H.I.G. Capital LLC, Novo A/S, Sevin Rosen Funds, Tarrant Capital IP LLC, Five Corners Capital Inc, Ventures West Management Inc, WRF Capital, Undisclosed Firms

Total Funding To Date (USD Mil): $105.30

Value of VCs’ shares at IPO price (USD Mil): $255.5

Total return to VCs at IPO price: 2.43x

Shares Beneficially owned by VCs After Offering:

• · Delphi Management Partners VII, LLC: 5,327,064
• · H.I.G. Venture Partners II, L.P.: 5,163,952
• · Ventures West 8 LP: 6,689,056
• · SRB Associates IX L.P.: 8,369,948
• · Total: 25,550,020

Value of VC shares at IPO price (USD Mil):

• · Delphi Management Partners VII, LLC: $53.27
• · H.I.G. Venture Partners II, L.P.: $51.64
• · Ventures West 8 LP: $66.89
• · SRB Associates IX L.P.: $83.7
• · Total: $255.5

IPO Details

Primary Exchange: Nasdaq

Ticker: ALDR

Time to Exit (Years): 8.7

Date Filed: 03/19/2014

Date Issued: 05/07/2014

Offer Price (USD): $10.00

First Day Closing Price (USD): $10.03

No. of Shares Offered + Overallot Sold All Mkts: 8,000,000

Proceeds Amt + Overallot Sold All Markets (USD Mil): $80.00

Post Offer Value (USD Mil): $299.0

Issuer’s Legal Advisor: Cooley LLP

Book Runner: Credit Suisse Securities (USA), Leerink Swann & Co

Co-Managers: Wells Fargo Securities LLC

Source: Thomson Reuters and company prospectus.